Literature DB >> 31313853

Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.

Ewan H Forrest1, Natasha Storey1, Rohit Sinha2, Stephen R Atkinson3, Nikhil Vergis3, Paul Richardson4, Steven Masson5, Stephen Ryder6, Mark R Thursz3, Michael Allison7, Andrew Fraser8, Andrew Austin9, Anne McCune10, Ashwin Dhanda11, Dev Katarey12, Jonathan Potts12, Sumita Verma12, Richard Parker13, Peter C Hayes2.   

Abstract

BACKGROUND: Treating severe alcoholic hepatitis involves the exposure of patients to corticosteroids for 7 days to assess "response". AIM: To assess the prognostic and therapeutic implications of baseline neutrophil-to-lymphocyte ratio (NLR) in patients with severe alcoholic hepatitis.
METHODS: Patients recruited to the STOPAH trial and an independent validation group were analysed retrospectively. Area under the receiver operating curve (AUC) analysis was performed. Kaplan-Meier analysis was used to assess survival. Log-rank test and odds ratio (OR) were used for comparative analysis.
RESULTS: Baseline NLR was available for 789 STOPAH patients. The AUC for NLR was modest for 90-day outcome (0.660), but was associated with infection, acute kidney injury (AKI) and severity of alcoholic hepatitis. Ninety-day survival was not affected by prednisolone treatment if NLR < 5 or > 8 but mortality was reduced with prednisolone treatment when the NLR was 5-8 (21.0% cf. 34.5%; P = 0.012). Prednisolone treatment increased the chance of Lille response if the NLR was  ≥ 5 (56.5% cf. 41.1%: P = 0.01; OR 1.86) but increased the risk of day 7 infection (17.3% cf. 7.4%: P = 0.006; OR 2.60) and AKI (20.8% cf. 7.0%: P = 0.008; OR 3.46) if the NLR was > 8. Incorporation of NLR into a modified Glasgow alcoholic hepatitis score (mGAHS) improved the AUC to 0.783 and 0.739 for 28-day and 90-day outcome, respectively.
CONCLUSION: The NLR is associated with AKI and infection in severe alcoholic hepatitis. The NLR identifies those most likely to benefit from corticosteroids at baseline (NLR 5-8). The mGAHS has a good predictive value for 28- and 90-day outcomes.
© 2019 Crown copyright. Alimentary Pharmacology and Therapeutics © 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31313853     DOI: 10.1111/apt.15335

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  17 in total

Review 1.  Alcoholic hepatitis: Towards an era of personalised management.

Authors:  Delphine Degré; Line C Ntandja Wandji; Christophe Moreno; Alexandre Louvet
Journal:  United European Gastroenterol J       Date:  2020-07-27       Impact factor: 4.623

Review 2.  Cirrhosis-associated immune dysfunction.

Authors:  Agustín Albillos; Rosa Martin-Mateos; Schalk Van der Merwe; Reiner Wiest; Rajiv Jalan; Melchor Álvarez-Mon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-26       Impact factor: 46.802

Review 3.  Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.

Authors:  Ashwani K Singal; Paul Kwo; Allison Kwong; Suthat Liangpunsakul; Alexandre Louvet; Pranoti Mandrekar; Craig McClain; Jessica Mellinger; Gyongyi Szabo; Norah Terrault; Mark Thursz; Gerald S Winder; W Ray Kim; Vijay H Shah
Journal:  Hepatology       Date:  2021-11-27       Impact factor: 17.298

4.  Analysis of high-risk factors for preoperative DVT in elderly patients with simple hip fractures and construction of a nomogram prediction model.

Authors:  Liang Zhang; Miao He; Wenlong Jia; Wenqing Xie; Ya Song; Haochen Wang; Jiangnan Peng; Yusheng Li; Zhaohui Wang; Zhangyuan Lin
Journal:  BMC Musculoskelet Disord       Date:  2022-05-11       Impact factor: 2.562

5.  Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.

Authors:  Peter S Harris; Cole R Michel; Youngho Yun; Courtney D McGinnis; Mohammed A Assiri; Ali Reza Ahmadi; Zhaoli Sun; James R Roede; Matthew A Burchill; David J Orlicky; Rebecca L McCullough; Kristofer S Fritz
Journal:  Alcohol       Date:  2021-12-17       Impact factor: 2.558

6.  Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.

Authors:  Lingxiong Chai; Kedan Cai; Kaiyue Wang; Qun Luo
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

7.  Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures.

Authors:  Dawei Liu; Yanbin Zhu; Wei Chen; Junyong Li; Kuo Zhao; Junzhe Zhang; Hongyu Meng; Yingze Zhang
Journal:  J Orthop Surg Res       Date:  2020-07-02       Impact factor: 2.359

8.  High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.

Authors:  Nicole E Rich; Aarthi Parvathaneni; Ahana Sen; Mobolaji Odewole; Ana Arroyo; Arjmand R Mufti; Thomas A Kerr; Lafaine Grant; Shannan R Tujios; Marlyn J Mayo; William M Lee; Ju Dong Yang; Takeshi Yokoo; Purva Gopal; Yujin Hoshida; Hao Zhu; Adam C Yopp; Jorge A Marrero; Amit G Singal
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.487

Review 9.  Recent advances in alcoholic hepatitis.

Authors:  Vikrant Rachakonda; Ramon Bataller; Andres Duarte-Rojo
Journal:  F1000Res       Date:  2020-02-10

10.  Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.

Authors:  Ayman Bannaga; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.